Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
申请人:ALLERGAN, INC.
公开号:US10899780B2
公开(公告)日:2021-01-26
The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2.
本发明涉及一种在需要治疗的受试者中治疗眼部炎症疾病的方法,该方法包括施用一种药物组合物,该药物组合物包含治疗有效量的至少一种甲酰肽受体 2 的激动剂。